Skip to main content

Funded Grants

Filter by:
Clear Filters
Filter by:

853 results found

Gangliosides in Huntington’s disease: from bench to clinics and back

Huntington disease (HD) is an inherited disorder that causes progressive malfunctioning and death of parts of the brain that control movement, reasoning and emotions.


Grant type
Team grants
Area of Research
Neurodegeneration
Competition
Brain Canada -Huntington Society of Canada HD Clinician-Scientist-to-Patent Virtual Networks Multi-Investigator
Province
Alberta
Start Date
2016

Cognitive Outcomes and Response/Remission Efficacy of Convulsive Therapies in Treatment Resistant Depression: The CORRECT-TRD Trial

Magnetic Seizure Therapy (MST) is a novel form of treatment that uses high intensity magnetic field pulses to stimulate the brain and induce a seizure as a therapeutic intervention for patients with depression resistant to antidepressant medication, known as Treatment Resistant Depression (TRD).


Grant type
Team grants
Area of Research
Mental Health
Competition
2015 MIRI Team Grants
Province
Ontario
Start Date
2016

Summer School in Computational Sensory Motor Neuroscience (CoSMo)

Major breakthroughs in neuroscience have been achieved through the application of computational models to empirical research.


Grant type
Capacity building grants
Area of Research
Neurotechnology
Competition
BRAIN Initiative
Province
Ontario
Start Date
2016

Reshaping Mitochondrial Efficiency and Integrity to Treat Parkinson’s Disease

Parkinson’s Disease (PD) is a debilitating neurodegenerative disease for which there is no cure.


Grant type
Team grants
Area of Research
Neurodegeneration
Competition
2015 MIRI Team Grants
Province
Ontario
Start Date
2016

Novel approaches to understand the role of cAMP and co-signaling cascades in synaptic plasticity and brain disorders

Synaptic plasticity is the process where the strength of connections between nerve cells is altered by experience.


Grant type
Team grants
Area of Research
Central Nervous System
Competition
2015 MIRI Team Grants
Province
Ontario
Start Date
2016

Testing therapeutic approaches to improve cognitive dysfunction in a primate model of Alzheimer’s Disease

Alzheimer’s Disease (AD) is a severe dementia that is likely a result of years of buildup in the brain of molecules called amyloid-beta oligomers (AβOs).


Grant type
Team grants
Area of Research
Neurodegeneration
Competition
2015 MIRI Team Grants
Province
Ontario
Start Date
2016

Toxicity Pathways and Catalytic Potential of Cu-Containing AB Oligomers

The protein fragment beta-amyloid has long been a key suspect in Alzheimer’s disease.


Grant type
Team grants
Area of Research
Neurodegeneration
Competition
Alzheimer's Association International Grant Program
Province
British Columbia
Start Date
2016

The Automated Monitoring of Gait as a Predictor of Fall Risk

People with dementia are at a high risk for falls which are a leading cause of injury and can contribute to loss of independence and quality of life.


Grant type
Team grants
Area of Research
Neurodegeneration
Competition
Alzheimer's Association International Grant Program
Province
Ontario
Start Date
2016

Preventing Language Decline in Dementia

Primary progressive aphasia (PPA) is a form of dementia which impairs the ability to understand spoken and written language but other cognitive skills (including memory) remain intact for several years after its onset.


Grant type
Team grants
Area of Research
Neurodegeneration
Competition
Alzheimer's Association International Grant Program
Province
Ontario
Start Date
2016

Novel blood and neuroimaging markers of Alzheimer’s disease and cerebral amyloid angiopathy

As our brains age, they become vulnerable to diseases such as Alzheimer’s disease which can cause dementia.


Grant type
Team grants
Area of Research
Neurodegeneration
Competition
2015 MIRI Team Grants
Province
Alberta
Start Date
2016